Home
OverviewAbout10 LeapsCollaborationImpact
OverviewLeaps TalksChapter FilmsLeaps.orgPartners
AgricultureHealth
OverviewAnnual ReviewBreakthrough StudyPress ReleasesIn the NewsReportsLeaps LeadershipPress KitMedia Contact
Team
  • Approach
    • Overview
    • About
    • 10 Leaps
    • Collaboration
    • Impact
  • Engagement
    • Overview
    • Leaps Talks
    • Chapter Films
    • Leaps.org
    • Partners
    • Agriculture
    • Health
  • News
    • Overview
    • Annual Review
    • Breakthrough Study
    • Press Releases
    • In the News
    • Reports
    • Leaps Leadership
    • Press Kit
    • Media Contact
  • Team
ContactImprintPrivacy StatementConditions of Use
sign up for our newsletter

In the news


Explore the latest Leaps investments, news on our companies, thought leadership, and press resources.

In the news

Press Releases


Press coverage of Leaps and portfolio companies


Leaps events


Spotlight on Juergen Eckhardt


Download Image

Juergen Eckhardt is EVP and Head of Leaps by Bayer, the impact investment arm, and Head of Business Development, & Licensing (BDL) for the Pharmaceuticals division. He is a medical doctor and venture investor in healthcare, biotech, and agriculture with more than 20 years of experience. He is a strong believer that scientific breakthroughs can help us overcome some of humanity’s biggest challenges, including to cure and prevent chronic disease and to feed an ever-growing world population in a sustainable way – in short: science for a better life. He holds an MD from the University of Basel, Switzerland, and an MBA from INSEAD in Fontainebleau, France.

Read More
Download Image
Juergen leaning against a red brick wall

Op-eds by Juergen Eckhardt


Reports


Explore the latest reports and publications developed by Leaps by Bayer and our collaborators.

  • Anual review 2023

    Read about our 2023 milestones, portfolio company highlights, engagement activities, and more.

    Download
  • LeapsbyBayer Ag Playbook 2024

    Learn how to bring AgTech products from concept to market.

    Download
  • Happiness Research Institute

    Read about the work with our partners at the Happiness Research Institute.

    Download
  • Taking 10 leaps for humanity

    See how our 10 Leaps framework could generate return for humanity.

    Download
  • Thumbnail

    Learn about our custom impact measurement framework WALY and read about the impact magnitude of our portfolio.

    Download

Press Kit


Leaps by Bayer is the impact investment arm of Bayer AG. We invest in teams pursuing fundamental breakthroughs in life science, targeting 10 huge challenges facing humanity.

Some call them impossible. We call them “Leaps”.

  • Press Kit Thumbnail

    Download the latest Press Kit

    Download
  • Juergen

    Download Juergen Eckhardt Photo

    Download
  • Juergen

    Download Juergen Eckhardt Photo

    Download

Media Contact


Kira Peikoff

Kira Peikoff is a former journalist who covered emerging biotechnologies for publications including The New York Times, Newsweek, and Popular Mechanics. She now leads communications for Leaps by Bayer.

Get in touch
https://staging.leaps.bayer.com/Kira-Peikoff-profile-image-2.webp

Our return
to humanity

The Leaps team brings together a diverse group of individuals with expertise in biotech, healthcare, agriculture, investment, and communication.

Explore Our Team
  • 02-13-2024

    Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M

    Read
  • 01-06-2024

    Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals

    Read
  • 11-09-2023

    Bayer and Recursion focus research collaboration on Oncology

    Read
  • 10-05-2023

    65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in Singapore

    Read
  • 08-29-2023

    Gene Editing: Pairwise and Bayer start new five-year multi-million Dollar collaboration to further advance short-stature corn

    Read
show more
  • March 15, 2024

    CoverCress named as one of the winners of the BloombergNEF Pioneers Award 2024

    BloombergNEF
  • January 30, 2024

    More people need transplants than there are organ donors. Pigs might be a solution

    CNN
  • August 31, 2023

    A Biotech Company Says It's Put Dopamine-Making Cells Into People's Brains

    MIT Tech Review
  • July 17, 2023

    Bat biotech takes flight

    Nature
  • May 18, 2023

    The First CRISPR Edited Salad Is Here

    Wired
  • May 16, 2023

    Boundless Bio Tests a Cancer Drug Targeting Once-Mysterious DNA Loops

    Stat
Show More

July 2023

Tech Open Air Berlin

Details

March 2023

World Agri Tech Summit

Details

March 2023

SXSW

Details

January 2023

JPM Healthcare Conference

Details

November 2022

MIT EmTech

Details

September 2022

Bayer Media Event

Details

April 2022

SynBioBeta

Details

November 2021

The New York Times Climate Hub at COP26

Details

October 2019

Boston HubWeek

Details

November 2017

Summit LA

Details
More Events
  • January 16, 2024

    Forbes logo

    Five Major Themes From The 2024 J.P. Morgan Healthcare Conference

    Read More
  • December 14, 2023

    Forbes logo

    Five Nobel-Winning Discoveries That Birthed New Medicines

    Read More
  • December 04, 2023

    Forbes Logo

    Five Ways Agriculture Can Help Solve The Climate Crisis

    Read More
  • November 16, 2023

    Forbes Logo

    Nobel Winner Drew Weissman Shares 7 Insights On Future mRNA Breakthroughs

    Read More
  • October 31, 2023

    Forbes Logo

    Why The Next Blockbuster Therapy May Come Out Of Singapore

    Read More
  • October 10, 2023

    Forbes Logo

    AI Chatbots—With Careful Guardrails—Can Help Treat Depression And Anxiety

    Read More
Show More